CorneaGen Revenue and Competitors
Estimated Revenue & Valuation
- CorneaGen's estimated annual revenue is currently $34.1M per year.
- CorneaGen's estimated revenue per employee is $193,750
- CorneaGen's total funding is $77M.
Employee Data
- CorneaGen has 176 Employees.
- CorneaGen grew their employee count by 21% last year.
CorneaGen's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Quality Assurance and Regulatory Affairs | Reveal Email/Phone |
2 | VP Distribution Services | Reveal Email/Phone |
3 | VP Marketing and Communications | Reveal Email/Phone |
4 | Chief Talent Management Officer | Reveal Email/Phone |
5 | Director Information Technology Infrastructure | Reveal Email/Phone |
6 | Director Shared Services | Reveal Email/Phone |
7 | Director Ocular Programs | Reveal Email/Phone |
8 | Director Distribution Services at CorneaGen Baltimore | Reveal Email/Phone |
9 | Director Business Applications | Reveal Email/Phone |
10 | Chief Commercial Officer | Reveal Email/Phone |
CorneaGen Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is CorneaGen?
CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. Based in Seattle, the company is innovating the next generation of cornea care, from new medical devices and biologics to therapeutics and interventions. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies. www.corneagen.com. New CorneaGen offerings include tissue storage media with antifungal Ampho B, the Geuder Preloaded Glass Cannula for DMEK and Intacs® corneal implants for keratoconus. These products join the recently acquired AcuFocus KAMRA Inlay in CorneaGen's growing line of innovative and affordable therapeutics for corneal surgeons.
keywords:N/A$77M
Total Funding
176
Number of Employees
$34.1M
Revenue (est)
21%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CorneaGen News
CorneaGen, which sells products for eye surgery, spun out Aurion to develop a cell therapy to address the limitations of current treatment...
Just under a year after spinning out from Seattle-based CorneaGen, Aurion Biotech has raised $120 million to bring its lead cell therapy...
Market Segment by Companies, this report covers: CorneaGen, Revision Optics, Refocus, Presbia. Market Segment by Type, covers: Corneal ...
SCOTTSDALE, Ariz. - At the Cornea360 meeting, Monty Montoya, president and CEO of CorneaGen, discusses the company's integration of ...
CorneaGen and KeraLink today announced that CorneaGen will be acquiring all of KeraLink's U.S. eye bank operations and related assets.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $300M | 176 | 8% | N/A |
#2 | $35M | 177 | 24% | N/A |
#3 | $34.5M | 178 | 23% | $148M |
#4 | $69.1M | 178 | 46% | N/A |
#5 | $23.6M | 179 | 7% | N/A |